China A-share innovative drug sector staged a volatile intraday rebound;
Nuosilande jumped nearly 20%, earlier Huashen Pharmaceutical and Haixin Co hit
daily limit-up, while Haoyuan Pharmaceutical, Joinn Laboratories, Changshan
Pharmaceutical and Shouyao Holdings also advanced.